Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Biomaterials Functionalized with Inflammasome Inhibitors - Premises and Perspectives

Version 1 : Received: 2 January 2024 / Approved: 3 January 2024 / Online: 4 January 2024 (09:25:17 CET)

A peer-reviewed article of this Preprint also exists.

Vinţeler, N.; Feurdean, C.N.; Petkes, R.; Barabas, R.; Boşca, B.A.; Muntean, A.; Feștilă, D.; Ilea, A. Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives. J. Funct. Biomater. 2024, 15, 32. Vinţeler, N.; Feurdean, C.N.; Petkes, R.; Barabas, R.; Boşca, B.A.; Muntean, A.; Feștilă, D.; Ilea, A. Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives. J. Funct. Biomater. 2024, 15, 32.

Abstract

The aim of this review was to search in literature, data regarding the inflammasome, involvement in, oral pathologies (mainly periodontitis) and other diseases and the approaches to control the inflammasome-related pathogenic mechanisms. The review also investigated how phytochemicals and pharmaceutical substances could be used to inhibit the inflammasome activity. Inflammasomes are involved in inflammatory, autoimmune and autoinflammatory diseases. Pharmaceutical substances can control the inflammasome by three mechanisms: inhibiting of intracellular signaling pathways (Allopurinol and SS-31), blocking inflammasome components (VX-765, Emricasan and VX-740), and inhibiting cytokines mediated by the inflammasome (Canakinumab, Anakinra and Rilonacept). Phytochemical inhibit the inflammasome, by neutralization of reactive oxygen species. Biomaterials functionalized by the adsorption of therapeutic agents on different nanomaterials may represent a future research direction to facilitate multimodal and sequential treatment in oral pathologies.

Keywords

inflammation; inflammasome; inhibitors of the inflammasome; nanomaterials; functionalized biomaterials; periodontitis; general pathology

Subject

Medicine and Pharmacology, Dentistry and Oral Surgery

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.